According to a new report from Intel Market Research, the global Nucleic Vaccine market was valued at USD 49.34 billion in 2024 and is projected to reach USD 59.64 billion by 2034, growing at a CAGR of 2.8% during the forecast period. This growth reflects the transformative impact of mRNA vaccine technology, particularly evident in the rapid response to the COVID-19 pandemic, alongside...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek